These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 39099360)
1. [Effect and mechanism of Compound Shougong Powder in attenuating triple-negative breast cancer progression by reversing epithelial-to-mesenchymal transition]. Jiao ZY; Zhu YF; Chen ST; Pan YX; Song H; Chen FY Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3868-3877. PubMed ID: 39099360 [TBL] [Abstract][Full Text] [Related]
2. Pomegranate peel extract inhibits expression of β-catenin, epithelial mesenchymal transition, and metastasis in triple negative breast cancer cells. Bagheri M; Fazli M; Saeednia S; Kor A; Ahmadiankia N Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):86-91. PubMed ID: 29974851 [TBL] [Abstract][Full Text] [Related]
3. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers. Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779 [TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting. Dong Q; Chen H; Li Y; Kong Y; Geng C; Liu Y Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):78-83. PubMed ID: 37715420 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition. Yar Saglam AS; Kayhan H; Alp E; Onen HI Mol Biol Rep; 2021 Jan; 48(1):475-489. PubMed ID: 33389483 [TBL] [Abstract][Full Text] [Related]
6. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation. Al-Marsoummi S; Vomhof-DeKrey E; Basson MD Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790 [TBL] [Abstract][Full Text] [Related]
7. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer. Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806 [TBL] [Abstract][Full Text] [Related]
8. Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells. Kashyap A; Umar SM; Dev J R A; Prasad CP Asian Pac J Cancer Prev; 2021 Jul; 22(7):2177-2184. PubMed ID: 34319041 [TBL] [Abstract][Full Text] [Related]
9. MAGE-A is frequently expressed in triple negative breast cancer and associated with epithelial-mesenchymal transition. Wang H; Sang M; Geng C; Liu F; Gu L; Shan B Neoplasma; 2016; 63(1):44-56. PubMed ID: 26639233 [TBL] [Abstract][Full Text] [Related]
10. The Antimicrobial Peptide Merecidin Inhibit the Metastasis of Triple-Negative Breast Cancer by Obstructing EMT via miR-30d-5p/Vimentin. Ma F; Song J; He M; Wang X Technol Cancer Res Treat; 2024; 23():15330338241281310. PubMed ID: 39267432 [No Abstract] [Full Text] [Related]
11. Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators. Rhodes LV; Tate CR; Segar HC; Burks HE; Phamduy TB; Hoang V; Elliott S; Gilliam D; Pounder FN; Anbalagan M; Chrisey DB; Rowan BG; Burow ME; Collins-Burow BM Breast Cancer Res Treat; 2014 Jun; 145(3):593-604. PubMed ID: 24810497 [TBL] [Abstract][Full Text] [Related]
12. Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model. Guo Y; Fan Y; Pei X Cancer Med; 2020 Apr; 9(7):2564-2578. PubMed ID: 32037729 [TBL] [Abstract][Full Text] [Related]
13. Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition. Das K; Paul S; Singh A; Ghosh A; Roy A; Ansari SA; Prasad R; Mukherjee A; Sen P J Biol Chem; 2019 Sep; 294(37):13681-13696. PubMed ID: 31341019 [TBL] [Abstract][Full Text] [Related]
14. Actinomycin V Inhibits Migration and Invasion via Suppressing Snail/Slug-Mediated Epithelial-Mesenchymal Transition Progression in Human Breast Cancer MDA-MB-231 Cells In Vitro. Lin S; Zhang C; Liu F; Ma J; Jia F; Han Z; Xie W; Li X Mar Drugs; 2019 May; 17(5):. PubMed ID: 31137656 [TBL] [Abstract][Full Text] [Related]
15. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism]. Rahimian A; Barati G; Mehrandish R; Mellati AA Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579 [TBL] [Abstract][Full Text] [Related]
16. The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells. Huang Q; Zheng S; Gu H; Yang Z; Lu Y; Yu X; Guo G Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(4):564-575. PubMed ID: 38449391 [TBL] [Abstract][Full Text] [Related]
17. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587 [TBL] [Abstract][Full Text] [Related]
18. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells. Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500 [TBL] [Abstract][Full Text] [Related]
19. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation. Pai JT; Chen XH; Leu YL; Weng MS Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593 [TBL] [Abstract][Full Text] [Related]
20. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP]. Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]